Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-01 Sale |
2021-02-02 9:47 pm |
Turning Point Therapeutics Inc. | TPTX | Larson Yi EVP & Chief Financial Officer |
30,000 | $126.73 | $3,801,918 | 581,796 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-14 Option Award |
2024-06-18 5:00 pm |
N/A 2034-06-14 |
Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director |
23,000 | $0 | 23,000 (Direct) |
View |
Ownership |
2023-09-14 7:27 pm |
N/A 2031-03-18 |
RayzeBio Inc. | RYZB | Larson Yi Director |
0 | $0 | 114,579 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2023-03-29 Option Award |
2023-03-31 4:17 pm |
N/A N/A |
LianBio | LIAN | Larson Yi Chief Financial Officer |
325,901 | $0 | 325,901 (Direct) |
View |
| 2023-01-20 Option Award |
2023-01-24 4:12 pm |
N/A 2033-01-20 |
LianBio | LIAN | Larson Yi Chief Financial Officer |
464,099 | $0 | 464,099 (Direct) |
View |
| 2022-06-17 Option Award(A) |
2022-06-27 5:16 pm |
N/A 2032-06-16 |
Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 7:32 pm |
N/A 2032-06-15 |
Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2021-12-01 Option Award |
2021-12-03 4:05 pm |
N/A 2031-12-01 |
LianBio | LIAN | Larson Yi Chief Financial Officer |
5,996 | $0 | 1,202,841 (Direct) |
View |
| 2021-10-31 Option Award |
2021-11-01 7:20 pm |
N/A 2031-10-31 |
LianBio | LIAN | Larson Yi Chief Financial Officer |
229,538 | $0 | 1,196,845 (Direct) |
View |
Ownership |
2021-10-29 6:16 pm |
N/A 2021-05-03 |
LianBio | LIAN | Larson Yi Chief Financial Officer |
0 | $0 | 969,307 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-10 6:36 pm |
N/A 2031-06-08 |
Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2021-04-05 Option Award |
2021-04-06 7:49 pm |
N/A 2031-04-04 |
Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director |
25,293 | $0 | 25,293 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 5:58 pm |
N/A 2031-02-07 |
Turning Point Therapeutics Inc. | TPTX | Larson Yi EVP & Chief Financial Officer |
25,392 | $0 | 28,096 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-02 9:47 pm |
N/A N/A |
Turning Point Therapeutics Inc. | TPTX | Larson Yi EVP & Chief Financial Officer |
30,000 | $54.03 | 581,796 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-02 9:47 pm |
N/A 2029-08-25 |
Turning Point Therapeutics Inc. | TPTX | Larson Yi EVP & Chief Financial Officer |
30,000 | $0 | 581,796 (Direct) |
View |